Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

University of Alberta

$27,000.00

Exploring the Impact of Sex Hormones on Symptoms, Lung Function, Exercise Capacity and Inflammation in Women with Cystic Fibrosis.

EF 2025-26

Résumé
A disparity in clinical outcomes between females and males has persisted even with current treatment options significantly increasing the life expectancy of people with cystic fibrosis (CF). Generally, women’s lives are marked by three stages of reproductive capacity, pre-menarche, menstrual years, and menopause, each associated with differing levels of sex hormones. Early work has demonstrated a possible link between hormone levels and pulmonary symptoms and inflammation in women with CF (WwCF). In the non-CF population, exertional capacity and endurance has been noted to vary throughout the menstrual cycle and given the link in WwCF between hormone levels and pulmonary symptoms, it might be reasonable to hypothesize that there may also be a link with exertional capacity. The aim of this project is to investigate how fluctuating hormonal levels link to pulmonary symptoms, function and inflammation at rest and during exercise in WwCF across the reproductive stages. Levels of estrogen, progesterone, testosterone, dehydroepiandrosterone sulfate (DHEAS) will be assessed during different phases of the menstrual cycle in women of reproductive age at rest and during exercise. The same will be done in a separate cohort of WwCF in menopause. Tests for blood and sputum inflammatory biomarkers and a CF pulmonary symptom measurement tool will be used to explore prevalence and severity of symptoms within each menstrual phase in context of changing hormonal levels. The project seeks to gain insight on the sex disparity in CF outcomes by exploring the influence of menstrual cycles and menopause on women with CF at baseline and during exercise.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
573036
Name
Mrazik Mackenzie J
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Exploring the Impact of Sex Hormones on Symptoms, Lung Function, Exercise Capacity and Inflammation in Women with Cystic Fibrosis.
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Cystic Fibrosis; Endurance; Exercise; Health Outcomes; Inflammation; Menopause; Menstruation; Pulmonary Symptoms; Sex Differences; Sex Hormones
Abstract
A disparity in clinical outcomes between females and males has persisted even with current treatment options significantly increasing the life expectancy of people with cystic fibrosis (CF). Generally, women’s lives are marked by three stages of reproductive capacity, pre-menarche, menstrual years, and menopause, each associated with differing levels of sex hormones. Early work has demonstrated a possible link between hormone levels and pulmonary symptoms and inflammation in women with CF (WwCF). In the non-CF population, exertional capacity and endurance has been noted to vary throughout the menstrual cycle and given the link in WwCF between hormone levels and pulmonary symptoms, it might be reasonable to hypothesize that there may also be a link with exertional capacity. The aim of this project is to investigate how fluctuating hormonal levels link to pulmonary symptoms, function and inflammation at rest and during exercise in WwCF across the reproductive stages. Levels of estrogen, progesterone, testosterone, dehydroepiandrosterone sulfate (DHEAS) will be assessed during different phases of the menstrual cycle in women of reproductive age at rest and during exercise. The same will be done in a separate cohort of WwCF in menopause. Tests for blood and sputum inflammatory biomarkers and a CF pulmonary symptom measurement tool will be used to explore prevalence and severity of symptoms within each menstrual phase in context of changing hormonal levels. The project seeks to gain insight on the sex disparity in CF outcomes by exploring the influence of menstrual cycles and menopause on women with CF at baseline and during exercise.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Mrazik, Mackenzie J
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~